CLEC-10A Antibodies

Santa Cruz Biotechnology features a diverse variety of CLEC-10A monoclonal antibodies for research focused on understanding this important immune system protein. CLEC-10A monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CLEC-10A, also known as Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN), plays a crucial role in the immune response by mediating interactions between dendritic cells and pathogens. CLEC-10A is essential for the recognition and uptake of glycosylated antigens, influencing the activation of T cells and the overall adaptive immune response. Understanding CLEC-10A function is vital for developing therapeutic strategies against various diseases, including infections and cancer. Researchers can explore immune system regulation through precise detection and characterization of CLEC-10A in their experimental work. The specificity and reliability of CLEC-10A monoclonal antibodies enable detailed investigation of immune cell interactions and signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for CLEC-10A support researchers worldwide in advancing our understanding of immune system function and potential therapeutic applications.